CymaBay Therapeutics, Inc. 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 23, 2017
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-19+100,000→ 100,000 totalExercise: $1.72Exp: 2027-01-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next three years.